NOT-CA-19-045: Notice of Correction to Award Information in RFA-CA-19-041 "Sustained Support for Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)"

Notice of Correction to Award Information in RFA-CA-19-041 "Sustained Support for Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)"

Notice Number: NOT-CA-19-045

Key Dates
Release Date: April 11, 2019

Related Announcements
RFA-CA-19-041

Issued by
National Cancer Institute (NCI)

Purpose

The purpose of this Notice is to correct the Award Information in RFA-CA-19-041 "Sustained Support for Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)".

Part 2. Full Text of Announcement, Section II. Award Information

Currently reads:

Application Types Allowed

New
Renewal
Resubmission

Should correctly read (in italics):

Application Types Allowed

New
Resubmission (allowable only for applications submitted originally to this RFA-CA-19-041)

Section V. Application Review Information, 1. Criteria, Additional Review Criteria

Currently reads:

Renewals

For Renewals, the committee will consider the progress made in the last funding period.

Should correctly read (in italics):

Renewals

Not Allowed

All other aspects of RFA-CA-19-041 remain unchanged.

Inquiries

Please direct all inquiries to:

Juli Klemm, Ph.D.
National Cancer Institute (NCI)
Telephone: 301-480-5778
Email:[email protected]

Referral Officer
National Cancer Institute (NCI)
Telephone: 240-276-6390
Email:[email protected]